Unrecognized Pseudohypoparathyroidism Type 1A as a Cause of Hypocalcemia and Seizures in a 64-Year-Old Woman

Patrizia Del Monte, Carla Micaela Cuttica, Alessandro Marugo, Luca Foppiani, Daniela Audenino, Tomasz Tadeusz Godowicz, Francesca Marta Elli, Giovanna Mantovani, Emilio Di Maria

Research output: Contribution to journalArticle

Abstract

Pseudohypoparathyroidism type 1A (PHP1A) is usually diagnosed in childhood or early adulthood. We describe the case of a 64-year-old woman admitted to the Neurological Unit for recurrent episodes of loss of consciousness and seizures. Glycemia and ECG were normal, while hypocalcemia was noted. Clinical history revealed carpo-pedal spasm since the age of 30 years, cognitive impairment, hypothyroidism since early adulthood, and menopause at 30 years. She was taking oral calcium and cholecalciferol for chronic hypocalcemia. Physical features suggested Albright's osteodystrophy. Blood calcium was confirmed low, with increased parathyroid hormone, moderate 25OH-vitamin D deficiency, and normal creatinine. Brain CT scan revealed calcifications of the basal ganglia, cortical and subcortical white matter, and cerebellum. Therapy was switched to oral calcitriol, with normalization of calcium levels; levetiracetam was started and no further seizures occurred. The clinical diagnosis of PHP1A was confirmed by molecular analysis, which demonstrated the heterozygous c.568_571del mutation of the GNAS gene. Our report illustrates the natural history of a patient with PHP1A, which went undiagnosed until the age of 64 years, with multi-hormonal resistance and clinical sequelae evolving throughout life, and underlines the importance of diagnosing this rare disease, which has a great impact on patients and their family life.

Original languageEnglish
Article number8456239
JournalCase Reports in Endocrinology
Volume2019
DOIs
Publication statusPublished - 2019

Fingerprint

Pseudohypoparathyroidism
Hypocalcemia
Seizures
etiracetam
Calcium
Vitamin D Deficiency
Unconsciousness
Calcitriol
Cholecalciferol
Spasm
Menopause
Rare Diseases
Hypothyroidism
Basal Ganglia
Natural History
Parathyroid Hormone
Cerebellum
Foot
Creatinine
Electrocardiography

Cite this

Del Monte, P., Cuttica, C. M., Marugo, A., Foppiani, L., Audenino, D., Godowicz, T. T., ... Di Maria, E. (2019). Unrecognized Pseudohypoparathyroidism Type 1A as a Cause of Hypocalcemia and Seizures in a 64-Year-Old Woman. Case Reports in Endocrinology, 2019, [8456239]. https://doi.org/10.1155/2019/8456239

Unrecognized Pseudohypoparathyroidism Type 1A as a Cause of Hypocalcemia and Seizures in a 64-Year-Old Woman. / Del Monte, Patrizia; Cuttica, Carla Micaela; Marugo, Alessandro; Foppiani, Luca; Audenino, Daniela; Godowicz, Tomasz Tadeusz; Elli, Francesca Marta; Mantovani, Giovanna; Di Maria, Emilio.

In: Case Reports in Endocrinology, Vol. 2019, 8456239, 2019.

Research output: Contribution to journalArticle

Del Monte, P, Cuttica, CM, Marugo, A, Foppiani, L, Audenino, D, Godowicz, TT, Elli, FM, Mantovani, G & Di Maria, E 2019, 'Unrecognized Pseudohypoparathyroidism Type 1A as a Cause of Hypocalcemia and Seizures in a 64-Year-Old Woman', Case Reports in Endocrinology, vol. 2019, 8456239. https://doi.org/10.1155/2019/8456239
Del Monte, Patrizia ; Cuttica, Carla Micaela ; Marugo, Alessandro ; Foppiani, Luca ; Audenino, Daniela ; Godowicz, Tomasz Tadeusz ; Elli, Francesca Marta ; Mantovani, Giovanna ; Di Maria, Emilio. / Unrecognized Pseudohypoparathyroidism Type 1A as a Cause of Hypocalcemia and Seizures in a 64-Year-Old Woman. In: Case Reports in Endocrinology. 2019 ; Vol. 2019.
@article{cc8d88e8e179485896cfe09a2dfd1e73,
title = "Unrecognized Pseudohypoparathyroidism Type 1A as a Cause of Hypocalcemia and Seizures in a 64-Year-Old Woman",
abstract = "Pseudohypoparathyroidism type 1A (PHP1A) is usually diagnosed in childhood or early adulthood. We describe the case of a 64-year-old woman admitted to the Neurological Unit for recurrent episodes of loss of consciousness and seizures. Glycemia and ECG were normal, while hypocalcemia was noted. Clinical history revealed carpo-pedal spasm since the age of 30 years, cognitive impairment, hypothyroidism since early adulthood, and menopause at 30 years. She was taking oral calcium and cholecalciferol for chronic hypocalcemia. Physical features suggested Albright's osteodystrophy. Blood calcium was confirmed low, with increased parathyroid hormone, moderate 25OH-vitamin D deficiency, and normal creatinine. Brain CT scan revealed calcifications of the basal ganglia, cortical and subcortical white matter, and cerebellum. Therapy was switched to oral calcitriol, with normalization of calcium levels; levetiracetam was started and no further seizures occurred. The clinical diagnosis of PHP1A was confirmed by molecular analysis, which demonstrated the heterozygous c.568_571del mutation of the GNAS gene. Our report illustrates the natural history of a patient with PHP1A, which went undiagnosed until the age of 64 years, with multi-hormonal resistance and clinical sequelae evolving throughout life, and underlines the importance of diagnosing this rare disease, which has a great impact on patients and their family life.",
author = "{Del Monte}, Patrizia and Cuttica, {Carla Micaela} and Alessandro Marugo and Luca Foppiani and Daniela Audenino and Godowicz, {Tomasz Tadeusz} and Elli, {Francesca Marta} and Giovanna Mantovani and {Di Maria}, Emilio",
year = "2019",
doi = "10.1155/2019/8456239",
language = "English",
volume = "2019",
journal = "Case Reports in Endocrinology",
issn = "2090-651X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Unrecognized Pseudohypoparathyroidism Type 1A as a Cause of Hypocalcemia and Seizures in a 64-Year-Old Woman

AU - Del Monte, Patrizia

AU - Cuttica, Carla Micaela

AU - Marugo, Alessandro

AU - Foppiani, Luca

AU - Audenino, Daniela

AU - Godowicz, Tomasz Tadeusz

AU - Elli, Francesca Marta

AU - Mantovani, Giovanna

AU - Di Maria, Emilio

PY - 2019

Y1 - 2019

N2 - Pseudohypoparathyroidism type 1A (PHP1A) is usually diagnosed in childhood or early adulthood. We describe the case of a 64-year-old woman admitted to the Neurological Unit for recurrent episodes of loss of consciousness and seizures. Glycemia and ECG were normal, while hypocalcemia was noted. Clinical history revealed carpo-pedal spasm since the age of 30 years, cognitive impairment, hypothyroidism since early adulthood, and menopause at 30 years. She was taking oral calcium and cholecalciferol for chronic hypocalcemia. Physical features suggested Albright's osteodystrophy. Blood calcium was confirmed low, with increased parathyroid hormone, moderate 25OH-vitamin D deficiency, and normal creatinine. Brain CT scan revealed calcifications of the basal ganglia, cortical and subcortical white matter, and cerebellum. Therapy was switched to oral calcitriol, with normalization of calcium levels; levetiracetam was started and no further seizures occurred. The clinical diagnosis of PHP1A was confirmed by molecular analysis, which demonstrated the heterozygous c.568_571del mutation of the GNAS gene. Our report illustrates the natural history of a patient with PHP1A, which went undiagnosed until the age of 64 years, with multi-hormonal resistance and clinical sequelae evolving throughout life, and underlines the importance of diagnosing this rare disease, which has a great impact on patients and their family life.

AB - Pseudohypoparathyroidism type 1A (PHP1A) is usually diagnosed in childhood or early adulthood. We describe the case of a 64-year-old woman admitted to the Neurological Unit for recurrent episodes of loss of consciousness and seizures. Glycemia and ECG were normal, while hypocalcemia was noted. Clinical history revealed carpo-pedal spasm since the age of 30 years, cognitive impairment, hypothyroidism since early adulthood, and menopause at 30 years. She was taking oral calcium and cholecalciferol for chronic hypocalcemia. Physical features suggested Albright's osteodystrophy. Blood calcium was confirmed low, with increased parathyroid hormone, moderate 25OH-vitamin D deficiency, and normal creatinine. Brain CT scan revealed calcifications of the basal ganglia, cortical and subcortical white matter, and cerebellum. Therapy was switched to oral calcitriol, with normalization of calcium levels; levetiracetam was started and no further seizures occurred. The clinical diagnosis of PHP1A was confirmed by molecular analysis, which demonstrated the heterozygous c.568_571del mutation of the GNAS gene. Our report illustrates the natural history of a patient with PHP1A, which went undiagnosed until the age of 64 years, with multi-hormonal resistance and clinical sequelae evolving throughout life, and underlines the importance of diagnosing this rare disease, which has a great impact on patients and their family life.

U2 - 10.1155/2019/8456239

DO - 10.1155/2019/8456239

M3 - Article

C2 - 30729047

VL - 2019

JO - Case Reports in Endocrinology

JF - Case Reports in Endocrinology

SN - 2090-651X

M1 - 8456239

ER -